This is not the most recent version of the article. View current version (27 MAR 2014)

Intervention Protocol

Pharmacological interventions for avoidant personality disorder

  1. Uzair Ahmed1,
  2. Simon Gibbon2,
  3. Hannah Jones3,
  4. Nick Huband4,
  5. Michael Ferriter5,*,
  6. Birgit A Völlm4,
  7. Jutta M Stoffers6,7,
  8. Klaus Lieb7,
  9. Jane A Dennis8,
  10. Conor Duggan4

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 7 SEP 2011

DOI: 10.1002/14651858.CD009304


How to Cite

Ahmed U, Gibbon S, Jones H, Huband N, Ferriter M, Völlm BA, Stoffers JM, Lieb K, Dennis JA, Duggan C. Pharmacological interventions for avoidant personality disorder (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD009304. DOI: 10.1002/14651858.CD009304.

Author Information

  1. 1

    North Yorkshire and York PCT, York, UK

  2. 2

    St Andrew's Healthcare, Northampton, UK

  3. 3

    University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  4. 4

    University of Nottingham Innovation Park, Forensic Mental Health, Institute of Mental Health, Nottingham, UK

  5. 5

    Nottinghamshire Healthcare NHS Trust, Forensic Division, Woodbeck, Nottinghamshire, UK

  6. 6

    University Medical Center Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany

  7. 7

    University Medical Center Mainz, Department of Psychiatry and Psychotherapy, Mainz, Germany

  8. 8

    Queen's University, c/o Developmental, Psychosocial and Learning Problems Group, Belfast, UK

*Michael Ferriter, Forensic Division, Nottinghamshire Healthcare NHS Trust, The Clair Chilvers Centre, Rampton Hospital, Woodbeck, Nottinghamshire, DN22 0PD, UK. Michael.Ferriter@nottshc.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 SEP 2011

SEARCH

This is not the most recent version of the article. View current version (27 MAR 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to evaluate the potential beneficial and adverse effects of pharmacological interventions for people with avoidant personality disorder.